東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Impact of risk disclosures through d...

Nikam, Prashant Tukaram.

Linked to FindBook

Google Book

Amazon

博客來

Impact of risk disclosures through direct-to-consumer advertising on elderly consumers' behavioral intent.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Impact of risk disclosures through direct-to-consumer advertising on elderly consumers' behavioral intent./
Author:	Nikam, Prashant Tukaram.
Description:	159 p.
Notes:	Source: Dissertation Abstracts International, Volume: 64-06, Section: B, page: 2618.
Contained By:	Dissertation Abstracts International64-06B.
Subject:	Health Sciences, Pharmacy. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3093683

Impact of risk disclosures through direct-to-consumer advertising on elderly consumers' behavioral intent.
Nikam, Prashant Tukaram.

Impact of risk disclosures through direct-to-consumer advertising on elderly consumers' behavioral intent. - 159 p.

Source: Dissertation Abstracts International, Volume: 64-06, Section: B, page: 2618.

Thesis (Ph.D.)--The Ohio State University, 2003.

The new FDA guidelines on Direct-to-Consumer Advertising (DTCA) of prescription drugs require the sponsor to present balanced benefit-risk information. However, data suggest frequent lack of compliance with these guidelines. Misinformation to consumers can have serious implications on health and safety. The study objective was to explore the impact of variations in risk disclosures through DTC print advertisements on consumer attitudes and behaviors. A 2 x 2 factorial design was implemented, where the risk statements in the advertisements varied in number and specificity. A convenience sample of 240 elderly (≥60 years) male and female participants was recruited. The participants were asked to read a print advertisement and then complete a questionnaire.Subjects--Topical Terms:

1017737
Health Sciences, Pharmacy.

Impact of risk disclosures through direct-to-consumer advertising on elderly consumers' behavioral intent.
LDR:03221nmm 2200301 4500 001 1862420
005 20041202093445.5
008 130614s2003 eng d
035 $a (UnM)AAI3093683
035 $a AAI3093683
040 $a UnM $c UnM
100 1 $a Nikam, Prashant Tukaram. $3 1949974
245 1 0 $a Impact of risk disclosures through direct-to-consumer advertising on elderly consumers' behavioral intent.
300 $a 159 p.
500 $a Source: Dissertation Abstracts International, Volume: 64-06, Section: B, page: 2618.
500 $a Adviser: Dev S. Pathak.
502 $a Thesis (Ph.D.)--The Ohio State University, 2003.
520 $a The new FDA guidelines on Direct-to-Consumer Advertising (DTCA) of prescription drugs require the sponsor to present balanced benefit-risk information. However, data suggest frequent lack of compliance with these guidelines. Misinformation to consumers can have serious implications on health and safety. The study objective was to explore the impact of variations in risk disclosures through DTC print advertisements on consumer attitudes and behaviors. A 2 x 2 factorial design was implemented, where the risk statements in the advertisements varied in number and specificity. A convenience sample of 240 elderly (≥60 years) male and female participants was recruited. The participants were asked to read a print advertisement and then complete a questionnaire.
520 $a Participants exposed to specific risk statements were less likely to look for additional information (p < 0.01) and adopt the advertised drug (p < 0.01). Additionally, they held less favorable attitudes toward the advertised drug (p < 0.01) as compared to those presented with general risk statements. The number of risk statements presented had no significant effect on attitudes or behaviors. However, a two-way interaction effect of number and specificity of risk statements on likelihood of adoption was observed. This interaction demonstrates that when participants were exposed to two risk statements, they did not significantly differ in adoption rates as a function of specificity. However, when exposed to four risk statements, specificity had a significant impact on adoption of the advertised drug, such that participants receiving four specific risk statements were less likely to adopt the advertised drug. These findings have significant implications health policy.
520 $a Presentation of highly specific risk information can adversely affect healthcare seeking behavior. Thus, drug manufacturers should aim at providing fair balance of benefit-risk information to lay consumers without compromising public health. There is also a need to re-evaluate and develop explicit FDA guidelines on fair balance of risk information presented in DTCA. Furthermore, the current research indicates that highly specific drug risk information can heighten perceived risk, which may result in reduced compliance.
590 $a School code: 0168.
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Business Administration, Marketing. $3 1017573
650 4 $a Psychology, Social. $3 529430
690 $a 0572
690 $a 0338
690 $a 0451
710 2 0 $a The Ohio State University. $3 718944
773 0 $t Dissertation Abstracts International $g 64-06B.
790 1 0 $a Pathak, Dev S., $e advisor
790 $a 0168
791 $a Ph.D.
792 $a 2003
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3093683